Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Granisetron 1mg tablets
0406000M0AAABAB
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | 96 |
|
Kytril 1mg tablets
0406000M0BBABAB
|
Kytril | Granisetron hydrochloride | Central Nervous System | 3 |
|
Granisetron 2mg tablets
0406000M0AAADAD
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | 2 |
|
Granisetron 3mg/3ml solution for injection ampoules
0406000M0AAAAAA
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | 1 |
|
Granisetron 1mg/1ml solution for injection ampoules
0406000M0AAAFAF
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | No data available |
|
Granisetron 200micrograms/ml oral solution sugar free
0406000M0AAAEAE
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | No data available |
|
Kytril 1mg/1ml solution for injection ampoules
0406000M0BBAFAF
|
Kytril | Granisetron hydrochloride | Central Nervous System | No data available |
|
Kytril 200micrograms/ml liquid paediatric
0406000M0BBAEAE
|
Kytril | Granisetron hydrochloride | Central Nervous System | No data available |
|
Kytril 2mg tablets
0406000M0BBADAD
|
Kytril | Granisetron hydrochloride | Central Nervous System | No data available |
|
Kytril 3mg/3ml solution for injection ampoules
0406000M0BBAAAA
|
Kytril | Granisetron hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.